MedPath

Role of Bilateral Repetitive Transcranial Magnetic Stimulation in Stroke Patients

Phase 3
Conditions
Nervous System Diseases
Registration Number
PACTR201907882363035
Lead Sponsor
Dina Ahmed El Salmawy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
55
Inclusion Criteria

-Patients presenting by their first ischemic or hemorrhagic cerebrovascular stroke within >two weeks from onset so patients could have passed the flaccid stage and < six months duration of symptoms, as the best cortical plasticity is obtained in a period less than six months(Takeuchi et al., 2009).
-Subcortical hemispheric stroke confirmed by magnetic resonance imaging (MRI).
-Patients of a minor (1-4) to moderate (5-15) national institutes of health stroke scale score (Lyden, Lu & Levine, 2001) to allow patient to receive treatment and perform tests (Wolf Motor function test and Fugl Meyer assessment) to assess improvement with minimum assistance.
-No prior experience of rTMS to confirm blindness of the intervention

Exclusion Criteria

-Family history of epilepsy or patients who are known to be epileptic.
-Pregnant females.
-Convulsion after the stroke onset
-Patients with any medical metal devices incompatible with transcranial magnetic stimulation (pacemaker).
-Bi-hemispheric or multifocal stroke.
-Premorbid lower motor neuron impairment prior to the onset of stroke like peripheral neuropathy or radiculopathy.Other comorbidities as fracture or deformity.
-Patients with heart failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assesment Of bilateral rtms therapy (Stimulatory 5Hz rTMS over the affected hemisphere alternated by inhibitory 1Hz rTMS over the non-affected hemisphere) could lead to an improvement in the motor function of the paretic hand in stroke patients
Secondary Outcome Measures
NameTimeMethod
improvement of post stroke spascity if present
© Copyright 2025. All Rights Reserved by MedPath